Betaxolol

DRUG3 trials

Sponsors

Region Vaesterbotten, National Eye Institute (NEI), Smith-Kettlewell Eye Research Institute

Conditions

Development of Side Effects From BetaxololGlaucomaOpen-Angle Glaucomaopen-angle and PEX glaucoma

Phase 1

Topical Betaxolol for the Prevention of Retinopathy of Prematurity

CompletedNCT01660620

Smith-Kettlewell Eye Research InstituteDevelopment of Side Effects From Betaxolol

Start: 2011-04-30End: 2011-11-30Updated: 2013-01-03

Phase 3

Early Manifest Glaucoma Trial (EMGT)

National Eye Institute (NEI)Open-Angle Glaucoma

Start: 1992-10-31Updated: 2005-06-24

Phase 4

Glaucoma Intensity Treatment Study – Intensive non-invasive glaucoma treatment vs conventional stepwise treatment – a prospective, randomized phase IV study of disease progression in glaucoma

Active, not recruitingCTIS2023-510041-16-00

Region VaesterbottenGlaucoma, open-angle and PEX glaucoma

Start: 2013-04-22Target: 240Updated: 2024-05-16